Frontline Combination CAR-T Cell Therapy

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Frontline Combination CAR-T Cell Therapy, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma [Phase 1, Phase 2]